Quick Dispatch:
Your tirzepatide surpass 5 Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide surpass 5 Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT ships.
Need Help?
Questions about tirzepatide surpass 5 Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide surpass 5 Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT in your area.
Results of SURPASS-1-5 for tirzepatide treatment in T2D
20.46
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program | Cardiovascular Diabetology
24.92
At a glance factsheet: Tirzepatide for management of type 2 diabetes
25.23
Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity
28.77
Changes in HbA1c from baseline to end of treatment in SURPASS 1-5 [10-14]
22.83
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
27.56
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
23.24
.png)
